" class="no-js "lang="en-US"> Amanda Pritchard Archives - Page 2 of 2 - Medtech Alert
Saturday, September 13, 2025

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

NHS to Offer Booster Booking to Every Adult by End of December

The NHS vaccination programme will offer every adult the chance to book a covid-19 booster […]

More People With Diabetes Set to Benefit From Blood Sugar Monitors as NHS Roll-Out Succeeds

Half of NHS Type 1 diabetes patients in England are now benefiting from the use […]

NHS Deal On Spinal Muscular Atrophy (SMA) First Home Treatment

A life-changing drug that can improve mobility in children and adults with a rare genetic […]

Thousands Spared Strokes Thanks to New NHS Drug Agreements

More than 20,000 strokes and 5,000 deaths could be averted after NHS England struck new […]

Former Vaccine Chief Returns As NHS Prepares For Winter

NHS chief executive Amanda Pritchard today announced that former vaccine chief Dr Emily Lawson is returning […]

NHS Announces Deal for Life Changing Sickle Cell Treatment

The first treatment for sickle cell disease in over 20 years will be rolled out […]

NHS Launches World’s Largest Trial of Cancer Blood Test

The NHS will today launch the world’s largest trial of a revolutionary new blood test […]

Additional £5.4 Billion for NHS Covid Response Over Next Six Months

The NHS will receive an extra £5.4 billion over the next six months to support […]

Amanda Pritchard Appointed NHS Chief Executive

Amanda Pritchard has today been appointed as the new Chief Executive Officer of NHS England. […]

NHS’s £160M Accelerator Sites to Tackle Waiting Lists

The NHS has today announced a £160 million initiative to tackle waiting lists and develop […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more